A pentasaccharide for monitoring pharmacodynamic response to gene therapy in GM1 gangliosidosis is a research paper published in EBioMedicine (2023). On theSindex it has a DataRank of 0. It has been cited 21 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: P30 DK020579
National Institutes of Health
Grant: R01HD060576
National Institutes of Health
Grant: U01NS114156
National Human Genome Research Institute
Grant: ZIAHG200409
National Institutes of Health
Grant: 1ZIAHG200409-01
Pathogenesis informs therapy in the GM1 and GM2 Gangliosidoses
National Institutes of Health
Grant: 5U01NS114156-04
Validation of analytical methods for quantification of a pentasaccharide biomarker in efficacy assessment of AVV treatment for GM1 gangliosidosis
National Institutes of Health
Grant: 2P30DK020579-36
Diabetes Research Center
National Institutes of Health
Grant: 5R01HD060576-03
Gene Therapy for Neurodegenerative Lysosomal Storage Diseases
National Tay-Sachs and Allied Diseases Association
FWCI
2.93
Citation Percentile
0.9%
Citation Trend
Fields of Study
MeSH Terms
Keywords